Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Gerber Collision & Glass Signs Enterprise Agreement to License Mitchell Cloud Estimating
The organization’s U.S.
Workers' Comp
Article
Health Care Price Transparency: What Workers' Comp and Auto Insurers Need to Know
The recent One Big Beautiful Bill Act (BBB) Act mandates unprecedented health care price transparency that will significantly impact Property and C
Risk & Insurance
In the News
2025 Theo Award Winner: FedEx
Auto Casualty
Case Study
When Machines Miss the Meaning
Mitchell
News Release
Mitchell Recognized as a 2025 Stratus Award Winner for Its Transformative, AI-Powered Claims Automation Solutions
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage
Workers' Comp
Article
Understanding Compliance and Regulatory Trends in Workers’ Comp Costs
As the regulatory landscape continues to shift at both the federal and state levels, understanding how these changes influence workers’ compensatio